Activated CaMKIIδ translocates to the RyR nanodomain in cardiomyocytes
Cardiovascular Research · 22.11.2025 · 121 (14) · 2177-2188
DOI: 10.1093/cvr/cvaf187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 10.10.2025. Verfasst von Anna Bergan-Dahl und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, PB 4956, NO-0424 Oslo, Norway. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Myocytes, Cardiac, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Calcium Signaling. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: South-Eastern Norway Regional Health Authority, NHLBI NIH HHS, Norwegian Research Council.
Abstract (Originalsprache)
Aims
The heartbeat is triggered by the coordinated release of Ca2+ from the ryanodine receptor type-2 (RyR) in cardiomyocytes. Phosphorylation of RyR by Ca2+/calmodulin-dependent kinase IIδ (CaMKIIδ) fine-tunes this process in health, while hyperphosphorylation causes excessive, pathological Ca2+ release. We investigated how CaMKIIδ is spatially recruited and anchored to RyRs to achieve this functional regulation. Methods and results We employed confocal and dSTORM microscopy to investigate the macro- and nanoscale distribution of CaMKIIδ across cardiomyocytes, respectively. We linked positional rearrangement of the kinase during β-adrenergic stimulation (isoproterenol, Iso) to alterations in RyR phosphorylation and function (Ca2+ sparks), and the requirement of the CaMKIIδ anchoring protein AKAP18δ by knockdown/knockout. Confocal microscopy revealed that macroscale CaMKIIδ localization was not markedly altered during Iso-treatment, although a narrowing of its distribution around the Z-lines occurred, where the RyR reside. Higher resolution dSTORM imaging confirmed that local mobilization of CaMKIIδ by Iso decreased the distance from Z-lines and RyRs to the nearest CaMKIIδ by 28 and 12%, respectively. Functionally, kinase translocation into the RyR nanodomain was accompanied by increased channel phosphorylation and Ca2+ spark frequency. These actions were dependent on CaMKIIδ activity, since kinase translocation, RyR phosphorylation, and activation were all mimicked by the upstream activator of CaMKIIδ (8-CPT) and prevented by direct CaMKIIδ inhibitors (AIP, N1 peptide). A critical role of AKAP18δ in this mechanism was supported by immunoprecipitation experiments, which showed greater kinase binding to AKAP18δ during Iso-stimulation. Furthermore, loss of AKAP18δ by viral-mediated AKAP18δ knockdown or knockout prevented CaMKIIδ translocation to Z-lines. Microtubular disruption also blocked CaMKIIδ translocation.
Conclusion
Collectively, our results indicate that nanoscale movement of CaMKIIδ is closely associated with RyR activation following β-adrenergic stimulation. This translocation depends on an intact microtubular network and kinase binding to AKAP18δ.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, PB 4956, NO-0424 Oslo, Norway.
- Laboratory of Systems Biology, Department of Cybernetics, School of Science, Tallinn University of Technology, 12618 Tallinn, Estonia.
- The University Medical Center Hamburg-Eppendorf, D-20246 Hamburg, Germany.
- Max-Delbrück-Centre for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.
- German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, 10785 Berlin, Germany.
- Department of Pharmacology, University of California Davis, 451 Health Sciences Drive, Davis, CA 95616, USA.
ORCID-Profile: Anna Bergan-Dahl, Ornella Manfra, Donald M Bers, William E Louch
Förderung
- South-Eastern Norway Regional Health Authority
- NHLBI NIH HHS
- Norwegian Research Council
- US National Institutes of Health
Zitieren
APA
Bergan-Dahl, A., Carlson, C. R., Laasmaa, M., Subramanian, H., Basson, A., Li, J., Hasic, A., Lunde, M., Ugland, H., Manfra, O., Klussmann, E., Bossuyt, J., Bers, D. M., Nikolaev, V. O., Louch, W. E., & Shen, X. (2025). Activated CaMKIIδ translocates to the RyR nanodomain in cardiomyocytes. Cardiovascular Research, 121(14), 2177-2188. https://doi.org/10.1093/cvr/cvaf187
Vancouver
Bergan-Dahl A, Carlson CR, Laasmaa M, Subramanian H, Basson A, Li J, et al. Activated CaMKIIδ translocates to the RyR nanodomain in cardiomyocytes. Cardiovascular Research. 2025;121(14):2177-2188. doi:10.1093/cvr/cvaf187
BibTeX
@article{BerganDahl2025,
author = {Bergan-Dahl, Anna and Carlson, Cathrine R and Laasmaa, Martin and Subramanian, Hariharan and Basson, Adelle and Li, Jia and Hasic, Almira and Lunde, Marianne and Ugland, Hege and Manfra, Ornella and Klussmann, Enno and Bossuyt, Julie and Bers, Donald M and Nikolaev, Viacheslav O and Louch, William E and Shen, Xin},
title = {Activated CaMKIIδ translocates to the RyR nanodomain in cardiomyocytes},
journal = {Cardiovascular Research},
year = {2025},
volume = {121},
number = {14},
pages = {2177--2188},
doi = {10.1093/cvr/cvaf187}
}
EUVIMED